Cargando…
Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO study): study protocol for a prospective, multicentre, single-arm trial
BACKGROUND: Dose reduction of tyrosine kinase inhibitors (TKI) in patients with chronic myeloid leukaemia (CML) with an optimal response to TKIs may support cost-effective medication use by maintaining therapeutic effectiveness while reducing adverse events and medication costs. As the choice for do...
Autores principales: | Djodikromo, Melissa F, Hermens, Rosella PMG, Bemt, Bart JF van den, Smit, Yolba, Govers, Tim M, Bekker, Charlotte L, Blijlevens, Nicole MA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007754/ https://www.ncbi.nlm.nih.gov/pubmed/36899295 http://dx.doi.org/10.1186/s12885-023-10697-6 |
Ejemplares similares
-
PB1978: PATIENT-CENTREDNESS IS PIVOTAL IN A PROSPECTIVE DOSE REDUCTION TRIAL OF TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
por: Djodikromo, Melissa, et al.
Publicado: (2023) -
A comprehensive eHealth implementation guide constructed on a qualitative case study on barriers and facilitators of the digital care platform CMyLife
por: Verweij, Lynn, et al.
Publicado: (2022) -
Effectiveness of digital care platform CMyLife for patients with chronic myeloid leukemia: results of a patient-preference trial
por: Verweij, Lynn, et al.
Publicado: (2023) -
Repository Rodeo Redux
por: Anez, Melissa, et al.
Publicado: (2017) -
Return of the Repository Rodeo
por: Wilcox, David, et al.
Publicado: (2018)